Chronic immune checkpoint inhibitor pneumonitis

BACKGROUND: Pneumonitis from immune checkpoint inhibitors (ICI) is a potentially fatal immune-related adverse event (irAE) from antiprogrammed death 1/programmed death ligand 1 immunotherapy. Most cases of ICI pneumonitis improve or resolve with 4–6 weeks of corticosteroid therapy. Herein, we report...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Immunother Cancer
Auteurs principaux: Naidoo, Jarushka, Cottrell, Tricia R, Lipson, Evan J, Forde, Patrick M, Illei, Peter B, Yarmus, Lonny B, Voong, K Ranh, Feller-Kopman, David, Lee, Hans, Riemer, Joanne, Wang, Daphne, Taube, Janis M, Brahmer, Julie R, Lin, Cheng Ting, Danoff, Sonye K, D'Alessio, Franco R, Suresh, Karthik
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2020
Sujets:
Short Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7304886/
https://ncbi.nlm.nih.gov/pubmed/32554618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000840
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires